Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

PHASE3CompletedINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

April 30, 2009

Conditions
Smoking Cessation
Interventions
DRUG

placebo

1mg (placebo) by mouth twice daily for 12 weeks (first week is up titration schedule---0.5mg once daily for 3 days, 0.5mg twice daily for 4 days)

DRUG

Varenicline Tartarate

1 mg by mouth twice daily for 12 weeks (first week is up titration schedule---0.5mg once daily for 3 days, 0.5mg twice daily for 4 days)

Trial Locations (32)

10003

Pfizer Investigational Site, Cáceres

14609

Pfizer Investigational Site, Rochester

19107

Pfizer Investigational Site, Philadelphia

27103

Pfizer Investigational Site, Winston-Salem

27157

Pfizer Investigational Site, Winston-Salem

27517

Pfizer Investigational Site, Chapel Hill

27607

Pfizer Investigational Site, Raleigh

28015

Pfizer Investigational Site, Madrid

29609

Pfizer Investigational Site, Brest

31029

Pfizer Investigational Site, Vittorio Veneto, TV

33143

Pfizer Investigational Site, Miami

34295

Pfizer Investigational Site, Montpellier

37203

Pfizer Investigational Site, Nashville

40509

Pfizer Investigational Site, Lexington

41100

Pfizer Investigational Site, Modena

55905

Pfizer Investigational Site, Rochester

56124

Pfizer Investigational Site, Pisa

75679

Pfizer Investigational Site, Paris

80206

Pfizer Investigational Site, Denver

35249-2181

Pfizer Investigational Site, Birmingham

90095-1690

Pfizer Investigational Site, Los Angeles

90095-6984

Pfizer Investigational Site, Los Angeles

06030-2810

Pfizer Investigational Site, Farmington

06030

Pfizer Investigational Site, Farmington

04102

Pfizer Investigational Site, Portland

02747

Pfizer Investigational Site, North Dartmouth

68198-5885

Pfizer Investigational Site, Omaha

27599-7020

Pfizer Investigational Site, Chapel Hill

97239-3098

Pfizer Investigational Site, Portland

77030-1608

Pfizer Investigational Site, Houston

06000

Pfizer Investigational Site, Nice

08907

Pfizer Investigational Site, L'hospitalet Del Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY